315 related articles for article (PubMed ID: 15581597)
1. Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids.
Spiecker M; Liao JK
Arch Biochem Biophys; 2005 Jan; 433(2):413-20. PubMed ID: 15581597
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids.
Sun J; Sui X; Bradbury JA; Zeldin DC; Conte MS; Liao JK
Circ Res; 2002 May; 90(9):1020-7. PubMed ID: 12016269
[TBL] [Abstract][Full Text] [Related]
3. Cardiac and vascular KATP channels in rats are activated by endogenous epoxyeicosatrienoic acids through different mechanisms.
Lu T; Ye D; Wang X; Seubert JM; Graves JP; Bradbury JA; Zeldin DC; Lee HC
J Physiol; 2006 Sep; 575(Pt 2):627-44. PubMed ID: 16793897
[TBL] [Abstract][Full Text] [Related]
4. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
Xu X; Zhang XA; Wang DW
Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627
[TBL] [Abstract][Full Text] [Related]
5. To move or not to move? Cytochrome P450 products and cell migration.
Fleming I
Circ Res; 2002 May; 90(9):936-8. PubMed ID: 12016258
[No Abstract] [Full Text] [Related]
6. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.
Node K; Huo Y; Ruan X; Yang B; Spiecker M; Ley K; Zeldin DC; Liao JK
Science; 1999 Aug; 285(5431):1276-9. PubMed ID: 10455056
[TBL] [Abstract][Full Text] [Related]
7. CYP2J subfamily P450s in the lung: expression, localization, and potential functional significance.
Zeldin DC; Foley J; Ma J; Boyle JE; Pascual JM; Moomaw CR; Tomer KB; Steenbergen C; Wu S
Mol Pharmacol; 1996 Nov; 50(5):1111-7. PubMed ID: 8913342
[TBL] [Abstract][Full Text] [Related]
8. CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice.
Chen G; Xu R; Zhang S; Wang Y; Wang P; Edin ML; Zeldin DC; Wang DW
Am J Physiol Endocrinol Metab; 2015 Jan; 308(2):E97-E110. PubMed ID: 25389366
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome p450 and vascular homeostasis.
Fleming I
Circ Res; 2001 Oct; 89(9):753-62. PubMed ID: 11679404
[TBL] [Abstract][Full Text] [Related]
10. CYP2J2 and EETs protect against lung ischemia/reperfusion injury via anti-inflammatory effects in vivo and in vitro.
Chen W; Yang S; Ping W; Fu X; Xu Q; Wang J
Cell Physiol Biochem; 2015; 35(5):2043-54. PubMed ID: 25870948
[TBL] [Abstract][Full Text] [Related]
11. Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids.
Shahabi P; Siest G; Visvikis-siest S
Drug Metab Rev; 2014 Feb; 46(1):33-56. PubMed ID: 24040964
[TBL] [Abstract][Full Text] [Related]
12. Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2.
Spiecker M; Darius H; Hankeln T; Soufi M; Sattler AM; Schaefer JR; Node K; Börgel J; Mügge A; Lindpaintner K; Huesing A; Maisch B; Zeldin DC; Liao JK
Circulation; 2004 Oct; 110(15):2132-6. PubMed ID: 15466638
[TBL] [Abstract][Full Text] [Related]
13. CYP2J2 and EETs Protect against Oxidative Stress and Apoptosis in Vivo and in Vitro Following Lung Ischemia/Reperfusion.
Chen W; Zheng G; Yang S; Ping W; Fu X; Zhang N; Wang DW; Wang J
Cell Physiol Biochem; 2014; 33(6):1663-80. PubMed ID: 24903033
[TBL] [Abstract][Full Text] [Related]
14. CYP2J subfamily cytochrome P450s in the gastrointestinal tract: expression, localization, and potential functional significance.
Zeldin DC; Foley J; Goldsworthy SM; Cook ME; Boyle JE; Ma J; Moomaw CR; Tomer KB; Steenbergen C; Wu S
Mol Pharmacol; 1997 Jun; 51(6):931-43. PubMed ID: 9187259
[TBL] [Abstract][Full Text] [Related]
15. CYP epoxygenase derived EETs: from cardiovascular protection to human cancer therapy.
Chen C; Wang DW
Curr Top Med Chem; 2013; 13(12):1454-69. PubMed ID: 23688135
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia.
Moshal KS; Zeldin DC; Sithu SD; Sen U; Tyagi N; Kumar M; Hughes WM; Metreveli N; Rosenberger DS; Singh M; Vacek TP; Rodriguez WE; Ayotunde A; Tyagi SC
J Cell Physiol; 2008 Jun; 215(3):771-81. PubMed ID: 18181170
[TBL] [Abstract][Full Text] [Related]
17. Cardiotonic Pill Reduces Myocardial Ischemia-Reperfusion Injury via Increasing EET Concentrations in Rats.
Xu M; Hao H; Jiang L; Wei Y; Zhou F; Sun J; Zhang J; Ji H; Wang G; Ju W; Li P
Drug Metab Dispos; 2016 Jul; 44(7):878-87. PubMed ID: 27149899
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 epoxygenase-derived 5,6-epoxyeicosatrienoic acid relaxes pulmonary arteries in normoxia but promotes sustained pulmonary vasoconstriction in hypoxia.
Strielkov I; Krause NC; Knoepp F; Alebrahimdehkordi N; Pak O; Garcia C; Ghofrani HA; Schermuly RT; Seeger W; Grimminger F; Sommer N; Weissmann N
Acta Physiol (Oxf); 2020 Sep; 230(1):e13521. PubMed ID: 32506676
[TBL] [Abstract][Full Text] [Related]
19. Capillary electrophoresis of cytochrome P-450 epoxygenase metabolites of arachidonic acid. 2. Resolution of stereoisomers.
Vandernoot VA; VanRollins M
Anal Chem; 2002 Nov; 74(22):5866-70. PubMed ID: 12463374
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase dependency of the renovascular actions of cytochrome P450-derived arachidonate metabolites.
Carroll MA; Garcia MP; Falck JR; McGiff JC
J Pharmacol Exp Ther; 1992 Jan; 260(1):104-9. PubMed ID: 1731035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
